Describe intubation conditions and adverse events when using atropine fentanyl +/- succinylcholine as premedication.
Prospective observational study, as part of a quality improvement initiative.
Two level 3 neonatal intensive care units in Ottawa, Canada
60 infants, median 27 weeks gestation, 1023 g at birth were included.
Infants received atropine, fentanyl +/- succinylcholine prior to the intubation. Succinylcholine was given for all infants > or =34 weeks and at the discretion of the physician for those